SAN DIEGO, CA / ACCESSWIRE / November 12, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Abiomed, Inc. (NASDAQ:ABMD) shares.
Investors, who purchased shares of Abiomed, Inc. (NASDAQ:ABMD) in January 2019 or earlier and continue to hold any of their NASDAQ: ABMD shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges that between the defendants made false and/or misleading statements and/or failed to disclose that ABIOMED's revenue growth was in decline, that the Company did not have a sufficient plan in place to stem its declining revenue growth, that the Company was unlikely to restore its revenue growth over the next several fiscal quarters, that consequently, ABIOMED was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company's prior projections and market expectations, and that as a result, the Company's.
Those who purchased Abiomed, Inc. (NASDAQ:ABMD) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.